Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

260
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
260
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  3. 研究领域
  5. 生物医学和临床科学
  7. 瘤学和致癌症
  9. 预测和预后标志物
  11. 使用临床变量,瘤大小和位置估计质母细胞瘤患者的整体存活率

使用临床变量,瘤大小和位置估计质母细胞瘤患者的整体存活率

Alexandros Ferles1,2, Paulina Majewska3,4, Ragnhild Holden Helland5,6

  • 1Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.

Neuro-oncology advances
|August 22, 2025

相关实验视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma
09:17

Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma

Published on: January 15, 2016

15.0K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K

在PubMed 上查看摘要

概括
此摘要是机器生成的。

临床因素和瘤特征显著影响质母细胞瘤的预后. 深度存活模型有效预测患者的存活率,帮助治疗决策.

关键词:
深度神经网络质母细胞瘤磁共振成像生存分析

相关实验视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.7K
Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma
09:17

Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma

Published on: January 15, 2016

15.0K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.0K

科学领域:

  • 神经瘤学
  • 医学成像分析
  • 医疗保健中的机器学习

背景情况:

  • 准确的质母细胞瘤预后对于有效的治疗计划和改善患者的结果至关重要.
  • 这项研究探讨了临床变量,瘤大小和质母细胞瘤的位置的预后价值.
  • 确定可靠的预后因素可以提高疾病管理策略.

研究的目的:

  • 评估临床变量,瘤大小和位置对质母细胞瘤患者生存的预后意义.
  • 为了比较不同的生存回归模型在预测整体生存的性能.
  • 确定患者治疗过程中预后评估的最佳阶段.

主要方法:

  • 一项回顾性多中心研究包括1318名质母细胞瘤患者.
  • 分析了手术前和手术后的MRI数据,以确定瘤的大小,位置和残留体积.
  • 使用C-指数和Brier分数进行了生存预测模型 (CoxPH,随机生存森林,DeepSurv) 的应用和评估.

主要成果:

  • 多变量考克斯分析证实了临床变量和瘤大小是显著的生存预测因素.
  • 在所有时间点中,DeepSurv模型表现出卓越的性能,C指数得分从61.71%到70.29%.
  • DeepSurv 的综合障碍评分在 7. 63% 至 8. 57% 之间.

结论:

  • 临床变量,瘤大小和位置是质母细胞瘤的重要预后指标.
  • 综合所有变量的深度生存模型提供了最好的预测准确性,特别是在化疗放射治疗的计划阶段.